image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 527.61
-1.89 %
$ 188 B
Market Cap
84.69
P/E
1. INTRINSIC VALUE

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights.[ Read More ]

The intrinsic value of one ISRG stock under the base case scenario is HIDDEN Compared to the current market price of 528 USD, Intuitive Surgical, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart ISRG

image
FINANCIALS
7.12 B REVENUE
14.49%
1.77 B OPERATING INCOME
45.86%
1.82 B NET INCOME
35.18%
1.81 B OPERATING CASH FLOW
21.67%
-360 M INVESTING CASH FLOW
-26.27%
-288 M FINANCING CASH FLOW
88.82%
2.04 B REVENUE
1.40%
577 M OPERATING INCOME
1.76%
571 M NET INCOME
8.29%
706 M OPERATING CASH FLOW
13.86%
-1.41 B INVESTING CASH FLOW
-202.50%
98.2 M FINANCING CASH FLOW
96.40%
Balance Sheet Decomposition Intuitive Surgical, Inc.
image
Current Assets 7.89 B
Cash & Short-Term Investments 5.22 B
Receivables 1.27 B
Other Current Assets 1.4 B
Non-Current Assets 7.55 B
Long-Term Investments 2.12 B
PP&E 3.54 B
Other Non-Current Assets 1.9 B
Current Liabilities 1.66 B
Accounts Payable 189 M
Short-Term Debt 0
Other Current Liabilities 1.47 B
Non-Current Liabilities 386 M
Long-Term Debt 64.5 M
Other Non-Current Liabilities 321 M
EFFICIENCY
Earnings Waterfall Intuitive Surgical, Inc.
image
Revenue 7.12 B
Cost Of Revenue 2.39 B
Gross Profit 4.73 B
Operating Expenses 2.96 B
Operating Income 1.77 B
Other Expenses -50.5 M
Net Income 1.82 B
RATIOS
66.39% GROSS MARGIN
66.39%
24.80% OPERATING MARGIN
24.80%
25.24% NET MARGIN
25.24%
13.51% ROE
13.51%
11.64% ROA
11.64%
12.32% ROIC
12.32%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Intuitive Surgical, Inc.
image
Net Income 1.82 B
Depreciation & Amortization 422 M
Capital Expenditures -1.06 B
Stock-Based Compensation 593 M
Change in Working Capital -778 M
Others 120 M
Free Cash Flow 750 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Intuitive Surgical, Inc.
image
Wall Street analysts predict an average 1-year price target for ISRG of $495 , with forecasts ranging from a low of $375 to a high of $604 .
ISRG Lowest Price Target Wall Street Target
375 USD -28.92%
ISRG Average Price Target Wall Street Target
495 USD -6.26%
ISRG Highest Price Target Wall Street Target
604 USD 14.48%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Intuitive Surgical, Inc.
image
Sold
0-3 MONTHS
42 M USD 9
3-6 MONTHS
20.1 M USD 7
6-9 MONTHS
34 M USD 7
9-12 MONTHS
49.4 M USD 7
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
5 days ago
Nov 12, 2024
Sell 2.15 M USD
Curet Myriam
EVP & Chief Medical Officer
- 4010
535.9569 USD
1 week ago
Nov 08, 2024
Sell 12 M USD
Samath Jamie
See Remarks
- 22903
525 USD
6 days ago
Nov 11, 2024
Sell 145 K USD
Samath Jamie
See Remarks
- 269
539.89 USD
6 days ago
Nov 11, 2024
Sell 64.2 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 119
539.89 USD
2 weeks ago
Oct 30, 2024
Sell 9.29 M USD
GUTHART GARY S
CEO
- 18151
511.6343 USD
2 weeks ago
Oct 30, 2024
Sell 1.9 M USD
GUTHART GARY S
CEO
- 3720
510.5179 USD
2 weeks ago
Oct 30, 2024
Sell 1.9 M USD
GUTHART GARY S
CEO
- 3720
510.7534 USD
3 weeks ago
Oct 25, 2024
Sell 96.6 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
514 USD
2 weeks ago
Oct 28, 2024
Sell 102 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 198
513.66 USD
2 weeks ago
Oct 29, 2024
Sell 95.2 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
506.52 USD
3 weeks ago
Oct 25, 2024
Sell 11.3 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 22
514 USD
2 weeks ago
Oct 28, 2024
Sell 11.3 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 22
513.66 USD
3 weeks ago
Oct 22, 2024
Sell 1.08 M USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 2106
515 USD
3 weeks ago
Oct 22, 2024
Sell 11.3 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 22
515 USD
3 weeks ago
Oct 23, 2024
Sell 11.3 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 22
513.89 USD
3 weeks ago
Oct 24, 2024
Sell 11.2 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 22
510.79 USD
3 weeks ago
Oct 22, 2024
Sell 1.31 M USD
Miller Brian Edward
EVP & Chief Digital Officer
- 2553
515 USD
2 months ago
Sep 13, 2024
Sell 221 K USD
Ladd Amy L
Director
- 450
490.28 USD
2 months ago
Sep 10, 2024
Sell 56.8 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 119
477.5 USD
2 months ago
Sep 09, 2024
Sell 142 K USD
LOEB GARY
General Counsel
- 300
475 USD
2 months ago
Aug 29, 2024
Sell 90.7 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
482.21 USD
2 months ago
Aug 28, 2024
Sell 90.8 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
482.93 USD
2 months ago
Aug 26, 2024
Sell 96.4 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 198
486.88 USD
2 months ago
Aug 23, 2024
Sell 223 K USD
Charlton Henry L
SVP & Chief Commercial and Mkt
- 459
486.8374 USD
2 months ago
Aug 23, 2024
Sell 650 K USD
Charlton Henry L
SVP & Chief Commercial and Mkt
- 1336
486.8484 USD
2 months ago
Aug 23, 2024
Sell 205 K USD
Charlton Henry L
SVP & Chief Commercial and Mkt
- 422
486.8117 USD
2 months ago
Aug 23, 2024
Sell 3.32 M USD
Charlton Henry L
SVP & Chief Commercial and Mkt
- 6828
486.8237 USD
2 months ago
Aug 23, 2024
Sell 3.32 M USD
Charlton Henry L
SVP & Chief Commercial and Mkt
- 6828
486.8614 USD
2 months ago
Aug 23, 2024
Sell 3.32 M USD
Charlton Henry L
SVP & Chief Commercial and Mkt
- 6829
486.8479 USD
3 months ago
Aug 12, 2024
Sell 55.8 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 120
464.76 USD
3 months ago
Aug 01, 2024
Sell 1.3 M USD
Johnson Amal M
Director
- 2943
443.3 USD
3 months ago
Jul 30, 2024
Sell 1.66 M USD
GUTHART GARY S
CEO
- 3720
445.0662 USD
3 months ago
Jul 30, 2024
Sell 1.66 M USD
GUTHART GARY S
CEO
- 3720
445.1165 USD
3 months ago
Jul 30, 2024
Sell 10.4 M USD
GUTHART GARY S
CEO
- 23388
443.0698 USD
3 months ago
Jul 26, 2024
Sell 82 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 187
438.6 USD
3 months ago
Jul 29, 2024
Sell 84 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
446.6 USD
3 months ago
Jul 23, 2024
Sell 641 K USD
BARRATT CRAIG H
Director
- 1400
458.13 USD
3 months ago
Jul 23, 2024
Sell 1.29 M USD
Curet Myriam
EVP & Chief Medical Officer
- 2818
458.13 USD
5 months ago
Jun 12, 2024
Sell 589 K USD
BARRATT CRAIG H
Director
- 1400
421.06 USD
5 months ago
Jun 10, 2024
Sell 50 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 120
416.6 USD
5 months ago
Jun 05, 2024
Sell 575 K USD
BARRATT CRAIG H
Director
- 1400
411 USD
5 months ago
Jun 03, 2024
Sell 442 K USD
BARRATT CRAIG H
Director
- 1096
402.89 USD
5 months ago
May 28, 2024
Sell 80.1 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 198
404.41 USD
5 months ago
May 29, 2024
Sell 74.6 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
396.59 USD
6 months ago
May 16, 2024
Sell 69.7 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 175
398.28 USD
6 months ago
May 17, 2024
Sell 25 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 63
396.19 USD
6 months ago
May 16, 2024
Sell 1.02 M USD
Miller Brian Edward
EVP & Chief Digital Officer
- 2553
400 USD
6 months ago
May 13, 2024
Sell 68.1 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 175
389.16 USD
6 months ago
May 14, 2024
Sell 66.6 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 175
380.85 USD
6 months ago
May 15, 2024
Sell 67.8 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 175
387.22 USD
6 months ago
May 13, 2024
Sell 35 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 90
389.16 USD
6 months ago
May 10, 2024
Sell 45.9 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 119
385.55 USD
6 months ago
May 13, 2024
Sell 75.5 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 194
389.16 USD
6 months ago
May 03, 2024
Sell 649 K USD
RUBASH MARK J
Director
- 1709
380 USD
6 months ago
Apr 29, 2024
Sell 70.6 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
375.39 USD
6 months ago
Apr 26, 2024
Sell 69.2 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 188
368.1 USD
6 months ago
Apr 26, 2024
Sell 148 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 396
375 USD
6 months ago
Apr 23, 2024
Sell 741 K USD
LEVY ALAN J
Director
- 2000
370.6988 USD
6 months ago
Apr 23, 2024
Sell 927 K USD
Curet Myriam
EVP & Chief Medical Officer
- 2500
370.6582 USD
8 months ago
Mar 15, 2024
Sell 243 K USD
Widman Fredrik
VP Corporate Controller
- 612
397.07 USD
8 months ago
Mar 08, 2024
Sell 178 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 453
393.8026 USD
8 months ago
Mar 08, 2024
Sell 592 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 1504
393.808 USD
8 months ago
Mar 08, 2024
Sell 2.82 M USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 7149
393.775 USD
8 months ago
Mar 08, 2024
Sell 178 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 453
393.7969 USD
8 months ago
Mar 08, 2024
Sell 566 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 1437
393.802 USD
8 months ago
Mar 08, 2024
Sell 370 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 940
393.8164 USD
8 months ago
Mar 08, 2024
Sell 1.11 M USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 2819
393.7942 USD
8 months ago
Mar 11, 2024
Sell 46.8 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 120
390.16 USD
8 months ago
Mar 08, 2024
Sell 1.08 M USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 2749
393.8309 USD
8 months ago
Mar 08, 2024
Sell 76.8 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 196
392.02 USD
8 months ago
Mar 11, 2024
Sell 76.5 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 196
390.16 USD
8 months ago
Mar 05, 2024
Sell 78.4 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 196
400 USD
8 months ago
Mar 06, 2024
Sell 75.8 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 196
386.76 USD
8 months ago
Mar 07, 2024
Sell 77.1 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 196
393.3 USD
8 months ago
Mar 01, 2024
Sell 615 K USD
Curet Myriam
EVP & Chief Medical Officer
- 1605
383.48 USD
8 months ago
Feb 28, 2024
Sell 2.64 M USD
MOHR MARSHALL
Executive VP Global Business S
- 6860
385.0815 USD
8 months ago
Feb 28, 2024
Sell 4.04 M USD
MOHR MARSHALL
Executive VP Global Business S
- 10500
385.0805 USD
8 months ago
Feb 28, 2024
Sell 5.29 M USD
MOHR MARSHALL
Executive VP Global Business S
- 13750
385.0794 USD
8 months ago
Feb 28, 2024
Sell 5.63 M USD
MOHR MARSHALL
Executive VP Global Business S
- 14620
385.0919 USD
8 months ago
Feb 28, 2024
Sell 4.91 M USD
MOHR MARSHALL
Executive VP Global Business S
- 12750
385.0805 USD
8 months ago
Feb 27, 2024
Sell 326 K USD
Curet Myriam
EVP & Chief Medical Officer
- 843
386.46 USD
9 months ago
Feb 14, 2024
Sell 11.4 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 30
380.09 USD
9 months ago
Feb 15, 2024
Sell 11.5 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 30
382.03 USD
9 months ago
Feb 16, 2024
Sell 12.1 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 32
378.29 USD
9 months ago
Feb 12, 2024
Sell 11.6 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 30
386.09 USD
9 months ago
Feb 13, 2024
Sell 11.3 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 30
375.505 USD
9 months ago
Feb 12, 2024
Sell 186 K USD
Curet Myriam
EVP & Chief Medical Officer
- 481
386.09 USD
9 months ago
Feb 07, 2024
Sell 6.11 M USD
Rosa David J.
President
- 15700
389.2856 USD
9 months ago
Feb 07, 2024
Sell 9 M USD
Rosa David J.
President
- 23120
389.2818 USD
9 months ago
Feb 07, 2024
Sell 6.29 M USD
Rosa David J.
President
- 16150
389.2276 USD
9 months ago
Feb 07, 2024
Sell 5 M USD
Rosa David J.
President
- 12840
389.3041 USD
9 months ago
Feb 07, 2024
Sell 5.02 M USD
Rosa David J.
President
- 12900
389.2867 USD
9 months ago
Feb 01, 2024
Sell 14.8 K USD
Brosius Mark
SVP & Chief Mfg and Supply Cha
- 39
378.41 USD
9 months ago
Jan 29, 2024
Sell 929 K USD
GUTHART GARY S
CEO
- 2480
374.41 USD
9 months ago
Jan 29, 2024
Sell 9.15 M USD
GUTHART GARY S
CEO
- 24325
376.0604 USD
9 months ago
Jan 26, 2024
Sell 555 K USD
Curet Myriam
EVP & Chief Medical Officer
- 1500
370.1478 USD
9 months ago
Jan 26, 2024
Sell 714 K USD
LEVY ALAN J
Director
- 1928
370.2024 USD
9 months ago
Jan 26, 2024
Sell 2.48 M USD
Johnson Amal M
Director
- 6696
370.0765 USD
1 year ago
Nov 16, 2023
Sell 2.87 M USD
Johnson Amal M
Director
- 9567
300 USD
1 year ago
Nov 16, 2023
Sell 450 K USD
Curet Myriam
EVP & Chief Medical Officer
- 1500
300 USD
1 year ago
Nov 14, 2023
Sell 78.3 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 270
290 USD
1 year ago
Nov 14, 2023
Sell 580 K USD
LEVY ALAN J
Director
- 2000
290 USD
1 year ago
Oct 24, 2023
Sell 674 K USD
GUTHART GARY S
CEO
- 2480
271.93 USD
1 year ago
Oct 26, 2023
Sell 7.12 M USD
GUTHART GARY S
CEO
- 27385
260.107 USD
1 year ago
Oct 24, 2023
Sell 155 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 564
275 USD
1 year ago
Oct 24, 2023
Sell 74.2 K USD
DeSantis Robert
EVP & Chief Strategy & Corp Op
- 273
271.93 USD
1 year ago
Sep 14, 2023
Sell 153 K USD
Ladd Amy L
Director
- 500
305.68 USD
1 year ago
Aug 07, 2023
Sell 144 K USD
LEVY ALAN J
Director
- 465
310 USD
1 year ago
Jul 31, 2023
Sell 808 K USD
GUTHART GARY S
CEO
- 2480
325.89 USD
1 year ago
Jul 28, 2023
Sell 16.4 M USD
GUTHART GARY S
CEO
- 50314
326.7626 USD
7. News
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know Zacks.com users have recently been watching Intuitive Surgical (ISRG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. zacks.com - 5 days ago
Will ISRG Stock Continue Its Uptrend After Gaining 9.9% in a Month? Intuitive Surgical has maintained an uptrend so far this year on the back of robust da Vinci portfolio performance. The stock also gained during the past month. zacks.com - 5 days ago
3 Soaring Stocks to Hold for the Next 20 Years These stocks may have done well this year, but here's the case for owning them for another two decades or more. fool.com - 1 week ago
Wall Street Analysts Think Intuitive Surgical (ISRG) Is a Good Investment: Is It? When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? zacks.com - 1 week ago
Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on It Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store. zacks.com - 2 weeks ago
These Are The Top Health Stocks to Own for Buy-and-Hold Investing Investors looking for health-related buy-and-hold stocks must look no further than this list. The stocks on this list are market leaders in healthcare, producing sustainable growth with healthy balance sheets, impressive value, and broad market support. marketbeat.com - 2 weeks ago
ISRG Stock To $5,000 Change imagined: ISRG stock long term forbes.com - 3 weeks ago
Got $1,000? 2 Healthcare Stocks to Buy and Hold Forever. These two stocks have moved in different directions this year, but that shouldn't mean much to long-term investors. fool.com - 3 weeks ago
Intuitive Surgical (ISRG) Is Considered a Good Investment by Brokers: Is That True? The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. zacks.com - 3 weeks ago
5 Monster Stocks to Hold for the Next 5 to 25 Years Each has an impressive history of share price performance and great prospects for further growth. fool.com - 3 weeks ago
Up 800% the Past Decade, Can the Momentum Continue for This Hot Stock? Intuitive Surgical continues to be one of the market's hottest stocks. fool.com - 3 weeks ago
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know Intuitive Surgical (ISRG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. zacks.com - 3 weeks ago
8. Profile Summary

Intuitive Surgical, Inc. ISRG

image
COUNTRY US
INDUSTRY Medical - Instruments & Supplies
MARKET CAP $ 188 B
Dividend Yield 0.00%
Description Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Contact 1020 Kifer Road, Sunnyvale, CA, 94086-5304 https://www.intuitive.com
IPO Date June 16, 2000
Employees 13676
Officers Mr. Brian King Vice President, Treasurer & Head of Investor Relations Mr. Henry L. Charlton Senior Vice President & Chief Commercial and Marketing Officer Mr. Fredrik Widman Vice President, Principal Accounting Officer & Corporate Controller Dr. Gary S. Guthart Ph.D. Chief Executive Officer & Director Ms. Patricia Wadors Chief Human Resources Officer Mr. Gary H. Loeb J.D. Senior Vice President, General Counsel & Chief Compliance Officer Mr. David J. Rosa President & Director Mr. Jamie E. Samath Senior Vice President & Chief Financial Officer Mr. Robert DeSantis Executive Vice President and Chief Strategy & Corporate Operations Officer Dr. Christopher R. Carlson Ph.D. Executive Vice President of Research, Corporate Development & Intuitive Ventures